UTZ:NYSEUtz Brands Inc Analysis
Data as of 2026-05-08 - not real-time
$7.72
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Utz Brands (UTZ) is trading just above a well‑defined support level while the 20‑day moving average sits marginally higher, indicating a narrow upside cushion. The 14‑day RSI hovers near the midpoint, suggesting neither overbought nor oversold conditions, and the MACD histogram is modestly positive despite a bearish overall trend. Volatility remains elevated at over 40% on a 30‑day basis, but the beta of roughly 0.65 points to less sensitivity to broader market swings. The stock’s dividend yield of about 3% and a payout ratio under 25% reinforce a degree of income stability.
Fundamentally, revenue growth is modest, margins are thin, and the company posted a negative trailing EPS, yet forward EPS is projected to turn positive, supporting a forward PE in the low‑double digits. The discounted cash‑flow model places fair value below the current price, but the price‑to‑book and price‑to‑sales multiples are sub‑one, hinting at a potentially fair valuation. With a dividend declared for the quarter and a strategic focus on brand expansion, the medium‑ to long‑term outlook leans toward incremental upside, provided the company can sustain cash flow and improve profitability.
Fundamentally, revenue growth is modest, margins are thin, and the company posted a negative trailing EPS, yet forward EPS is projected to turn positive, supporting a forward PE in the low‑double digits. The discounted cash‑flow model places fair value below the current price, but the price‑to‑book and price‑to‑sales multiples are sub‑one, hinting at a potentially fair valuation. With a dividend declared for the quarter and a strategic focus on brand expansion, the medium‑ to long‑term outlook leans toward incremental upside, provided the company can sustain cash flow and improve profitability.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- price near technical support
- stable dividend income
- elevated short‑term volatility
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- forward earnings improvement
- fair valuation relative to book and sales
- sustained dividend yield
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- defensive consumer staples positioning
- brand portfolio diversification
- potential for cash‑flow driven share repurchases
Key Metrics & Analysis
Financial Health
Revenue Growth2.60%
Profit Margin-0.58%
P/E Ratio9.2
ROE-1.16%
ROA0.27%
Debt/Equity64.42
P/B Ratio0.9
Op. Cash Flow$120.2M
Free Cash Flow$92.7M
Technical Analysis
TrendBearish
RSI47.9
Support$7.29
Resistance$8.68
MA 20$7.74
MA 50$7.85
MA 200$10.51
MACDBullish
VolumeStable
Fear & Greed Index90.93
Valuation
Fair Value$6.82
Target Price$11.95
Upside/Downside54.79%
GradeFair
TypeBlend
Dividend Yield3.04%
Risk Assessment
Beta0.66
Volatility44.27%
Sector RiskLow
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.